Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/31786
Title: | Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. | Authors: | Rogers P.A.W.;Roufail S.;Hibbs M.L.;Alitalo K.;Achen M.G.;Stacker S.A.;McColl B.K.;Paavonen K.;Karnezis T.;Harris N.C.;Davydova N.;Rothacker J.;Nice E.C.;Harder K.W. | Institution: | (McColl, Paavonen, Karnezis, Harris, Davydova, Rothacker, Nice, Harder, Roufail, Hibbs, Stacker, Achen) Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Vic., Australia (Rogers) Monash University, Department of Obstetrics and Gynaecology, Monash Medical Centre, Clayton, Vic., Australia (Alitalo) Molecular/Cancer Biology Laboratory, Ludwig Institute for Cancer Research, University of Helsinki, Helsinki, Finland (McColl) Ludwig Institute for Cancer Research, Royal Free and University College, Medical School Branch, 91 Riding House St., London W1W 7BS, United Kingdom (Harder) University of British Columbia, Department of Microbiology and Immunology, Life Sciences Centre, Vancouver, BC, Canada (Achen) Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Post Office Box 2008, Vic. 3050, Australia | Issue Date: | 16-Oct-2012 | Copyright year: | 2007 | Publisher: | FASEB (9650 Rockville Pike, Bethesda MD 20814-3998, United States) | Place of publication: | United States | Publication information: | FASEB Journal. 21 (4) (pp 1088-1098), 2007. Date of Publication: April 2007. | Abstract: | Vascular endothelial growth factor (VEGF)-D is a secreted glycoprotein that induces angiogenesis and lymphangiogenesis. It consists of a central domain, containing binding sites for VEGF receptor-2 (VEGFR-2) and VEGFR-3, and N- and C-terminal propeptides. It is secreted from the cell as homodimers of the full-length form that can be proteolytically processed to remove the propeptides. It was recently shown, using adenoviral gene delivery, that fully processed VEGF-D induces angiogenesis in vivo, whereas full-length VEGF-D does not. To better understand these observations, we monitored the effect of VEGF-D processing on receptor binding using a full-length VEGF-D mutant that cannot be processed. This mutant binds VEGFR-2, the receptor signaling for angiogenesis, with ~17,000-fold lower affinity than mature VEGF-D, indicating the importance of processing for interaction with this receptor. Further, we show that members of the proprotein convertase (PC) family of proteases promote VEGF-D processing, which facilitates the VEGF-D/VEGFR-2 interaction. The PCs furin and PC5 promote cleavage of both propeptides, whereas PC7 promotes cleavage of the C-terminal propeptide only. The finding that PCs promote activation of VEGF-D and other proteins with roles in cancer such as matrix metalloproteinases, emphasizes the importance of these enzymes as potential regulators of tumor progression and metastasis. © FASEB. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1096/fj.06-7060com | PubMed URL: | 17242158 [http://www.ncbi.nlm.nih.gov/pubmed/?term=17242158] | ISSN: | 0892-6638 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/31786 | Type: | Article |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.